About Hovione
Hovione is a company based in Loures (Portugal) founded in 1959. Hovione has completed 1 acquisition, including Imax Diagnostic. Hovione operates in a competitive market with competitors including Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.
- Headquarter Loures, Portugal
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hovione Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$321.78 K (USD), Grant
Mar 01, 2024
- Investors
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Hovione
Unlock access to complete
Software Development Team
87 people
Human Resources and Administration
25 people
Senior Team
22 people
Product Management Team
20 people
Sales and Marketing
18 people
Leadership Team
12 people
Finance and Accounting
8 people
QC Team
7 people
Unlock access to complete
Funding Insights of Hovione
Investors in Hovione
Hovione has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Hovione
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hovione
Hovione has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Imax Diagnostic.
Investment portfolio details for Hovione
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
APIs are manufactured and imaging services are provided.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Hovione
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Hovione
Detailed financials for Hovione
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hovione Comparisons
Peer comparison for Hovione
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hovione
Hovione operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Natco Pharma, Alembic Pharmaceuticals, Almac Group, Indoco Remedies and Concord Biotech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
APIs and finished dosage forms are developed and manufactured.
|
|
| Locked | Locked | Locked |
Manufacturer & supplier of generic pharmaceuticals
|
|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
Detailed competitors of Hovione
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hovione
Complete news archive for Hovione
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hovione
Hovione was founded in 1959 and raised its 1st funding round 65 years after it was founded.
Hovione is headquartered in Loures, Portugal.
Hovione is a CDMO with over 50 years of experience in the development and manufacture of drug substances and drug product intermediates through their FDA inspected sites in the USA, China, Ireland and Portugal. Hoviones CDMO services for drug substances drug products include development, manufacturing and particle engineering services. For drug products, they offer development services for oral and inhaled dosage forms with a special focus on dry powder inhalation formulations (conventional carrier-based, neat (drug-alone) or composite particle formulations) and devices(TwinCaps and PowdAir). Hovione has capabilities for spray drying, hot melt extrusion, nanoparticles, co-crystals,wet-polishing, jet milling, spray congealing and inclusion complexes. They employ tools such as QbD, PAT, Britest and lean technologies for efficient process development. For generic companies, they offer API products and specialise in antibiotics, corticosteroids, macrolides, mectins and contrast media products.The company also owns a product portfolio of dermatology, ophthalmology and respiratory products which are known APIs formulated with Hoviones expertise in the form of topical gels, sterile ointments, injections and other dosage forms. The company also offers analytical support services.
Hovione's top competitors include Natco Pharma, Concord Biotech and Alembic Pharmaceuticals.
Hovione has made 1 acquisition, including Imax Diagnostic.
Hovione has 1 investor. Key investors include European Union.